Pfizer PFE
NYSE PFE
$29.44 +0.08 (+0.27%)
As of: Nov 11, 2026 · 3:59 PM EST

Pfizer (PFE) Land & Improvements (2009 - 2011)

Updated

Pfizer (PFE) posted Land & Improvements of $747 million for Q4 2011, down 5.6% from $791 million a year earlier.

Analysis

Pfizer (PFE) Land & Improvements (2009 - 2011) Analysis & Trends

  • In prior years, Pfizer's Land & Improvements was $791 million in FY2010 (-15.6%) and $937 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 747.00 Mn
Dec 31, 2010 791.00 Mn
Dec 31, 2009 937.00 Mn
API Access

Pfizer Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=PFE&period=max&api_key=YOUR_API_KEY